PYC Therapeutics Limited (ASX:PYC)

PYC Therapeutics Revenue

PYC Therapeutics had revenue of 8.90M AUD in the half year ending December 31, 2025, a decrease of -0.06%. This brings the company's revenue in the last twelve months to 20.56M, down -17.73% year-over-year. In the fiscal year ending June 30, 2025, PYC Therapeutics had annual revenue of 23.49M with 6.51% growth.

• Revenue (ttm): 20.56M
• Revenue Growth: -17.73%
• P/S Ratio: 66.72
• Revenue / Employee: 4.11M
• Employees: 5
• Market Cap: 1.37B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	23.49M	1.44M	6.51%
Jun 30, 2024	22.06M	6.25M	39.56%
Jun 30, 2023	15.81M	-236.57K	-1.47%
Jun 30, 2022	16.04M	12.97M	421.83%
Jun 30, 2021	3.07M	678.66K	28.33%